{"transactions":[{"id":307456,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:13:10.000Z","date":"2026-07-01","kind":"sale","planned":true,"acquired":false,"shares":828,"price":502.71,"value":416243.88,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":19131,"source":{"system":"sec-edgar","filing":"0000875320-26-000241","document":"wk-form4_1783368787.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000241/wk-form4_1783368787.xml","form_type":"4"}},{"id":308824,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-06-03T20:06:33.000Z","date":"2026-06-01","kind":"sale","planned":true,"acquired":false,"shares":828,"price":439.91,"value":364245.48,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":19959,"source":{"system":"sec-edgar","filing":"0000875320-26-000230","document":"wk-form4_1780517191.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000230/wk-form4_1780517191.xml","form_type":"4"}},{"id":310075,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-05-05T21:11:22.000Z","date":"2026-05-01","kind":"sale","planned":true,"acquired":false,"shares":1104,"price":425.02,"value":469222.08,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":20729,"source":{"system":"sec-edgar","filing":"0000875320-26-000183","document":"wk-form4_1778015480.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000183/wk-form4_1778015480.xml","form_type":"4"}},{"id":310893,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-04-03T20:53:51.000Z","date":"2026-04-01","kind":"sale","planned":true,"acquired":false,"shares":978,"price":449.17,"value":439288.26,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":21833,"source":{"system":"sec-edgar","filing":"0000875320-26-000157","document":"wk-form4_1775249628.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000157/wk-form4_1775249628.xml","form_type":"4"}},{"id":312114,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP and Chief Legal Officer"}}],"security":"Common Stock","published_at":"2026-03-04T21:21:16.000Z","date":"2026-03-02","kind":"sale","planned":true,"acquired":false,"shares":892,"price":495.96,"value":442396.32,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1, which was entered into on 11/25/2025."}],"balance_after":22811,"source":{"system":"sec-edgar","filing":"0000875320-26-000134","document":"wk-form4_1772659274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000087532026000134/wk-form4_1772659274.xml","form_type":"4"}},{"id":358726,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":300,"price":305.57,"value":91671.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $305.57 (range $305.55 to $305.58)."}],"balance_after":9605,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358725,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":1743,"price":305.01,"value":531632.43,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $305.01 (range $304.54 to $305.53)."}],"balance_after":9905,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358724,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":700,"price":303.99,"value":212793.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $303.99 (range $303.48 to $304.46)."}],"balance_after":11648,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358723,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":100,"price":302.35,"value":30235.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."}],"balance_after":12348,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358722,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":698,"price":301.63,"value":210537.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $301.63 (range $301.23 to $302.01)."}],"balance_after":12448,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358721,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-17T21:36:17.000Z","date":"2022-08-15","kind":"sale","acquired":false,"shares":206,"price":300.26,"value":61853.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $300.26 (range $300.00 to $300.28)."}],"balance_after":13146,"source":{"system":"sec-edgar","filing":"0000899243-22-029023","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322029023/doc4.xml","form_type":"4"}},{"id":358865,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-12T20:05:18.000Z","date":"2022-08-10","kind":"sale","acquired":false,"shares":36,"price":300.32,"value":10811.52,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."}],"balance_after":13352,"source":{"system":"sec-edgar","filing":"0000899243-22-028470","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028470/doc4.xml","form_type":"4"}},{"id":358922,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-08-10T20:06:18.000Z","date":"2022-08-09","kind":"sale","acquired":false,"shares":946,"price":300,"value":283800.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."}],"balance_after":13388,"source":{"system":"sec-edgar","filing":"0000899243-22-028249","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322028249/doc4.xml","form_type":"4"}},{"id":361364,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:18:52.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":35,"price":254.36,"value":8902.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $254.36 (range $254.15 to $254.57)."}],"balance_after":14334,"source":{"system":"sec-edgar","filing":"0000899243-22-018604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322018604/doc4.xml","form_type":"4"}},{"id":361363,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:18:52.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":34,"price":253.87,"value":8631.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $253.87 (range $253.14 to $254.13)."}],"balance_after":14369,"source":{"system":"sec-edgar","filing":"0000899243-22-018604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322018604/doc4.xml","form_type":"4"}},{"id":361362,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:18:52.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":20,"price":252.49,"value":5049.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $252.49 (range $252.12 to $253.11)."}],"balance_after":14403,"source":{"system":"sec-edgar","filing":"0000899243-22-018604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322018604/doc4.xml","form_type":"4"}},{"id":361361,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:18:52.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":19,"price":251.57,"value":4779.83,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $251.57 (range $251.05 to $251.81)."}],"balance_after":14423,"source":{"system":"sec-edgar","filing":"0000899243-22-018604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322018604/doc4.xml","form_type":"4"}},{"id":361360,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-18T20:18:52.000Z","date":"2022-05-16","kind":"sale","acquired":false,"shares":25,"price":250.77,"value":6269.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $250.77 (range $250.00 to $250.90)."}],"balance_after":14442,"source":{"system":"sec-edgar","filing":"0000899243-22-018604","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322018604/doc4.xml","form_type":"4"}},{"id":362001,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-03T20:28:33.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":10,"price":278.04,"value":2780.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."}],"balance_after":14334,"source":{"system":"sec-edgar","filing":"0000899243-22-016320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016320/doc4.xml","form_type":"4"}},{"id":362000,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-03T20:28:33.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":22,"price":276.72,"value":6087.84,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $276.72 (range $276.31 to $277.06)."}],"balance_after":14344,"source":{"system":"sec-edgar","filing":"0000899243-22-016320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016320/doc4.xml","form_type":"4"}},{"id":361999,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-03T20:28:33.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":30,"price":275.62,"value":8268.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $275.62 (range $275.22 to $276.19)."}],"balance_after":14366,"source":{"system":"sec-edgar","filing":"0000899243-22-016320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016320/doc4.xml","form_type":"4"}},{"id":361998,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-03T20:28:33.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":41,"price":274.75,"value":11264.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $274.74 (range $274.20 to $275.14)."}],"balance_after":14396,"source":{"system":"sec-edgar","filing":"0000899243-22-016320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016320/doc4.xml","form_type":"4"}},{"id":361997,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-05-03T20:28:33.000Z","date":"2022-04-29","kind":"sale","acquired":false,"shares":17,"price":273.37,"value":4647.29,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the Issuer or a security holder of the Issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Open market sales reported on this line occurred at a weighted average price of $273.37 (range $273.13 to $273.87)."}],"balance_after":14437,"source":{"system":"sec-edgar","filing":"0000899243-22-016320","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322016320/doc4.xml","form_type":"4"}},{"id":365010,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-28T22:24:41.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":1554,"price":227.86,"value":354094.44,"ownership":{"direct":true},"balance_after":14454,"source":{"system":"sec-edgar","filing":"0000899243-22-008120","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322008120/doc4.xml","form_type":"4"}},{"id":365562,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-22T21:59:23.000Z","date":"2022-02-17","kind":"tax_withholding","acquired":false,"shares":712,"price":232.51,"value":165547.12,"ownership":{"direct":true},"balance_after":16008,"source":{"system":"sec-edgar","filing":"0000899243-22-007213","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000089924322007213/doc4.xml","form_type":"4"}},{"id":366086,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-14T21:18:26.000Z","date":"2022-02-10","kind":"tax_withholding","acquired":false,"shares":474,"price":237.74,"value":112688.76,"ownership":{"direct":true},"balance_after":16720,"source":{"system":"sec-edgar","filing":"0001209191-22-009238","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122009238/doc4.xml","form_type":"4"}},{"id":366665,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-03T21:21:56.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":3207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Restricted stock unit award that vests in installments beginning on 02/24/2023."}],"balance_after":17194,"source":{"system":"sec-edgar","filing":"0001209191-22-006786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006786/doc4.xml","form_type":"4"}},{"id":366664,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-03T21:21:56.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":3634,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/03/2021 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest in installments beginning on 02/17/2022."}],"balance_after":13987,"source":{"system":"sec-edgar","filing":"0001209191-22-006786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006786/doc4.xml","form_type":"4"}},{"id":366663,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2022-02-03T21:21:56.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":2100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents earned performance shares with respect to a performance stock unit award granted on 02/06/2019 that contained performance-vesting requirements. The issuer's management development and compensation committee certified as to the level of performance-goal attainment on 02/01/2022 and the shares will vest on 02/24/2022."}],"balance_after":10353,"source":{"system":"sec-edgar","filing":"0001209191-22-006786","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919122006786/doc4.xml","form_type":"4"}},{"id":375225,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-05-19T20:06:13.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":47,"price":216.88,"value":10193.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $215.95 (range $215.42 to $216.34)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $216.88 (range $216.43 to $217.21)."}],"balance_after":8253,"source":{"system":"sec-edgar","filing":"0001209191-21-033986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121033986/doc4.xml","form_type":"4"}},{"id":375224,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-05-19T20:06:13.000Z","date":"2021-05-17","kind":"sale","acquired":false,"shares":65,"price":215.95,"value":14036.75,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $215.95 (range $215.42 to $216.34)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":8300,"source":{"system":"sec-edgar","filing":"0001209191-21-033986","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121033986/doc4.xml","form_type":"4"}},{"id":378512,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":256,"price":212.28,"value":54343.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"Open market sales reported on this line occurred at a weighted average price of $212.28 (range $212.08 to $212.45)."}],"balance_after":8253,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}},{"id":378511,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":1460,"price":211.67,"value":309038.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"Open market sales reported on this line occurred at a weighted average price of $211.67 (range $211.08 to $212.07)."}],"balance_after":8509,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}},{"id":378510,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":844,"price":210.64,"value":177780.16,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"Open market sales reported on this line occurred at a weighted average price of $210.64 (range $210.00 to $210.97)."}],"balance_after":9969,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}},{"id":378509,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":111,"price":209.37,"value":23240.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"Open market sales reported on this line occurred at a weighted average price of $209.37 (range $208.98 to $209.64)."}],"balance_after":10813,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}},{"id":378508,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":1119,"price":208.39,"value":233188.41,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Open market sales reported on this line occurred at a weighted average price of $208.39 (range $207.93 to $208.67)."}],"balance_after":10924,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}},{"id":378507,"issuer":{"id":2875,"kind":"organization","name":"VERTEX PHARMACEUTICALS INC / MA","symbol":"VRTX"},"owners":[{"id":14445,"kind":"person","name":"Liu Joy","position":1,"cik":"0001847529","reported_name":"Liu Joy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, General Counsel"}}],"security":"Common Stock","published_at":"2021-03-08T21:10:30.000Z","date":"2021-03-05","kind":"sale","acquired":false,"shares":1351,"price":207.57,"value":280427.07,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Transaction made pursuant to Ms. Liu's company-approved trading plan under Rule 10b5-1."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Open market sales reported on this line occurred at a weighted average price of $207.57 (range $206.93 to $207.92)."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Ms. Liu undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price."}],"balance_after":12043,"source":{"system":"sec-edgar","filing":"0001209191-21-018528","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/875320/000120919121018528/doc4.xml","form_type":"4"}}]}